Add like
Add dislike
Add to saved papers

Sources and transformation pathways for dichlorodiphenyltrichloroethane (DDT) and metabolites in soils from Northwest Fujian, China.

Dicofol (2,2,2-trichloro-1,1-bis-(p-chlorophenyl)ethanol) found in the environment is not only a miticide originated from commercial use, but also a metabolite of dichlorodiphenyltrichloroethane (DDT), which is often overlooked. To verify the sources and transformation pathways of DDT and related metabolites in soils, we measured p,p'-(dicofol + DBP) (sum of p,p'-dicofol and 4,4'-dichlorobenzophenone), DDT and six metabolites in soils from Northwest Fujian, China. The ratios of 1,1,1-trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane (o,p'-DDT)/1,1,1-trichloro-2,2-bis-(p-chlorophenyl)ethane (p,p'-DDT) and the mass balance demonstrated that p,p'-(dicofol + DBP) predominantly originated from p,p'-DDT transformation rather than from actual dicofol application. p,p'-(dicofol + DBP) accounted for 45.0% as the primary metabolites of DDT in this study, more than 1,1-dichloro-2,2-bis-(p-chlorophenyl)ethylene (p,p'-DDE) and 1,1-dichloro-2,2-bis-(p-chlorophenyl)ethane (p,p'-DDD), which might lead to large overestimations of the fresh DDT input by using the traditional ratio of (∑2 DDD + ∑2 DDE)/∑2 DDT (with all o,p'- and p,p'- isomers included). In paddy fields where the conditions alternate between aerobic (dry period) and anaerobic (wet period), both p,p'-DDD and p,p'-DDE were likely to degrade to 1-chloro-2,2-bis-(p-chlorophenyl)ethylene (p,p'-DDMU), which further transformed to 2,2-bis(p-chlorophenyl)ethylene (p,p'-DDNU). Degradation of p,p'-DDMU to p,p'-DDNU mainly occurred in waterlogged paddy soils. However, p,p'-DDNU might not transform to other higher-order metabolites in aerobic surface soils. Overall, our study confirmed p,p'-(dicofol + DBP) as metabolites of p,p'-DDT, suggested DDE and DDD were parallel precursors of DDMU, and further verified the transformation pathways of DDT in surface soils.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app